Skip to main content

John Morrey

Profile Picture

Agricultural Experiment Station

Virology, Neurology

Research Professor



Biography

I am the Director of the Institute for Antiviral Research, which consists of a team of 10 PhD’s and 30 other employees that research therapies and vaccines for influenza, hemorrhagic fever, yellow fever, SARS, West Nile, hepatitis B, and others. I am most directly involved with the neurology and treatment of West Nile and of hepatitis.

Teaching Interests

No teaching appointment

Research Interests

My research activities are the pathobiology of viral encephalitis and treatments, using primarily West Nile virus, and secondarily other flaviviruses and alphaviruses causing encephalitis. I am also involved in research of hepatitis virus, influenza virus and prion disease.


Contact Information

Office Hours: Open
Go toOffice Location: Biotech 305
DialPhone: 435-797-2622
SendEmail: john.morrey@usu.edu

Awards

Researcher of the Year for the College of Agriculture, 2007

News article in Science citing transgenic research, 2003

James Legrand Shupe Achievement Award, 2002

Article in The Chronicles of Higher Education, 2001

Invited Participant for Liberty Foundation Colloguium, 2001

News article in Science citing West Nile virus research, 2000

Invited Participant for Liberty Foundation Colloguium, 2000

Co-organizer of Symposium, 2000

Co-organizer of Liberty Foundation Colloquium, 1999

Co-organizer of Symposium, 1998

Presentation Award, 1997

New article in Science featuring transgenic research, 1997

Article in Newsweek featuring animal cloning, 1997

1995-1996 USU Honors Professor, 1995

Editor's review article in Science, 1992

Staff Fellowship Award, 1987


  • Morrey, J.D, Siddharthan, V., Wang, H., Motter, N.E, Hall, J.O, (2010). Discovery and treatment of respiratory neurologic sequelae in west nile virus infected hamsters . Antiviral Res.
  • Morrey, J.D, (2001). Transgenic mice carrying a gene for green fluorescent protein fused to a lytic peptide, shiva 1, under control of the bovine B-casein regulatory region. Transgenics *
  • Morrey, J.D, (1999). Transgenic mice as a chemotherapeutic model for hepatitis B virus infection. Antiviral Ther. *
  • Morrey, J.D, (1995). Effect of the combination of interferon-alpha and stavudine on Friend virus infections in (B10.A X A.By)F1 mice. Journal of Infectious Diseases *
  • Morrey, J.D, (1994). Cytokines as potential therapies for human immunodeficiency virus infections. Canadian Journal of Infectious Diseases *
  • Morrey, J.D, (1992). Ganciclovir treatment of murine cytomegalovirus infection in mice immunosuppressed by prior infection with friend leukemia virus. Antiviral Chemistry and Chemotherapy
  • Morrey, J.D, (1992). Transgenic mice as models for photo-induced gene expression: Activation of human immunodeficiency virus long terminal repeat. Journal of Photochemistry and Photobiology *
  • Morrey, J.D, Bourn, S.M, Bunch, T.D, Sidwell, R.W, Barrows, L.R, Daynes, R.A, Rosen, C.A, (1991). In vitro activation of HIV-1 long terminal repeat by UV light and various skin applicants in transgenic mice. Journal Acquired Immune Deficiency Syndrome 4:328 *
  • Morrey, J.D, (1991). New models of murine cytomegalovirus infection in immunocompromised mice. Antiviral Res. 15(Suppl. 1):133 *
  • Morrey, J.D, (1989). Murine retroviral disease enhancing effects of a pyrimidinone immunomodulator. The Pharmacologist *
  • Morrey, J.D, (1989). Murine retroviral disease enhancing effects of a pyrimidinone immunomodulator. The Pharmacologist *

Publications - Books & Book Chapters

    Books

  • Morrey, J.D, (2002). Ethical Issues in Biotechnology.
  • Book Chapters

  • Morrey, J.D, (2000). Ethical issues in transgenics. Cloning
  • Morrey, J.D, (1999). Animal models for HBV infections - transgenic mice. Handbook of Animal Models of Infection *
  • Morrey, J.D, (1998). Transgenic mice as a chemotherapeutic model for HBV infection. Therapies for Viral Hepatitis *
  • Morrey, J.D, (1994). Effect of the combination of human recombinant alpha interferon-A/D and 2',3'-didehydro=2',3'-dideoxythymidine on murine retrovirus disease. Recent Advances in Chemotherapy *

* Has not been peer reviewed

Publications - Fact Sheets

    * Has not been peer reviewed

    Publications - Curriculum

      * Has not been peer reviewed

      Publications - Journal Articles

        Academic Journal

      • Julander, J.G, Siddharthan, V., Evans, J., Taylor, R., Tolbert, K., Apuli, C., Stewart, J., Collins, P., Gebre, M., Neilson, S., Van Wettere, A., Lee, Y., Sheridan, W.P, Morrey, J.D, Babu, Y., (2017). Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model. Antiviral Research (Antiviral Res), 137, 14-22. doi: 10.1016/j.antiviral.2016.11.003
      • Julander, J.G, Siddharthan, V., Evans, J., Taylor, R., Tolbert, K., Apuli, C., Stewart, J., Collins, P., Gebre, M., Neilson, S., Van Wettere, A., Lee, Y., Sheridan, W.P, Morrey, J.D, Babu, Y., (2017). Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model. Antiviral Research (Antiviral Res), 137, 14-22. doi: 10.1016/j.antiviral.2016.11.003
      • Zukor, K., Wang, H., Hurst, B.L, Siddharthan, V., Van Wettere, A., Pilowsky, P.M, Morrey, J.D, , Phrenic nerve deficits and neurological immunopathology associated with acute West Nile virus infection in mice and hamsters. Journal of Neurovirology
      • Yun, S., Song, B., Kim, J., Yun, G., Lee, E., Li, L., Kuhn, R., Rossmann, M., Morrey, J., Lee, Y., (2015). A molecularly cloned, live-attenuated Japanese encephalitis vaccine SA14-14-2 virus. World Biomedical Frontiers, 1, 1-4.
      • Siddharthan, V., Wang, H., Davies, C., Hall, J.O, Morrey, J.D, (2014). Inhibition of West Nile virus by calbindin-D28k. PLOS One, 9:9, e106535. doi: doi:10.1371/ journal.pone.0106535
      • Siddharthan, V., Wang, H., Davies, C., Hall, J.O, Morrey, J.D, (2014). Inhibition of West Nile virus by calbindin-D28k. PLOS One, 9, e106535.
      • Julander, J.G, Kesler, K., Van Wettere, A., Morrey, J.D, Smee, D., (2014). The use of plethysmography in determining the severity of lung pathology in a mouse model of minimally lethal influenza virus infection. Antiviral Research, 108, 10-13.
      • Julander, J., Kesler, K., Van Wettere, A., Morrey, J.D, Smee, D., (2014). The use of plethysmography in determining the severity of lung pathology in a mouse model of minimally lethal influenza virus infection. Antiviral Research, 108, 10-13. doi: 10.1016/j.antiviral.2014.05.002
      • Yun, S., Song, B., Kim, J., Yun, G., Lee, E., Li, L., Kuhn, R.J, Rossmann, M.G, Morrey, J.D, Lee, Y., (2014). A molecularly cloned, live-attenuated Japanese encephalitis vaccine SA14-14-2 virus: A conserved single amino acid in the ij hairpin of the viral E glycoprotein determines neurovirulence in mice. PLOS Pathogens (PLOS Pathog), 10:7, e1004290. doi: doi: 10.1371/journal.ppat.1004290
      • Julander, J., Thibodeaux, B., Morrey, J.D, Roehrig, J.T, Blair, C.D, (2014). Humanized monoclonal antibody 2C9-cIgG has enhanced efficacy for yellow fever prophylaxis and therapy in an immunocompetent animal model. Antiviral Research, 103, 32-38. doi: 10.1016/j.antiviral.2013.12.011
      • Petrovsky, N., Larena, M., Siddharthan, V., Prow, N.A, Hall, R.A, Lobigs, M., Morrey, J.D, (2013). An inactivated cell culture Japanese encephalitis vaccine (JE-ADVAX) formulated with delta inulin adjuvant provides robust heterologous protection against West Nile encephalitis via cross-protective memory B cells and neutralizing antibody.. Journal of Virology, 87, 10324-10333.
      • Smee, D., Tarbet, B., Furuta, Y., Morrey, J.D, Barnard, D., (2013). Synergistic combinations of favipiravir and oseltamivir against wild-type pandemic and oseltamivir-resistant influenza A virus infections in mice. Antiviral Research, 8:11, 1085-1094.
      • Morrey, J.D, Siddharthan, V., Wang, H., (2013). Neurological approaches for investigating West Nile virus disease and its treatment in rodents. Antiviral Research, 100, 535-535.
      • Roth, J.P, Li, J.K, Morrey, J.D, Barnard, D.L, Vollmer, A.H, (2013). Deletion of the D domain of the human parainfluenza virus type 3 (HPIV3) PD protein results in decreased viral RNA synthesis and beta interferon (IFN-b) expression. Virus Genes/Springer, 47, 10. doi: 10.1007/s11262-013-0919-x
      • Wang, H., Siddharthan, V., Kessler, K.K, Hall, J.O, Motter, N.E, Julander, J., Morrey, J.D, (2013). Fatal neurological respiratory insufficiency is common among viral encephalitides. The Journal of Infectious Diseases, 208:4, 573-83.
      • Tarbet, B., Maekawa, M., Furuta, Y., Babu, Y., Morrey, J.D, Smee, D., (2012). Combinations of Favipiravir and Peramivir for the Treatment of Pandemic Influenza A/California/04/2009 (H1N1) Virus Infections in Mice. . Antiviral Research, 94:(1), 103-110.
      • Morrey, J.D, S.V, W.H, Hall, J.O, (2012). Respiratory Insufficiency Correlated Strongly with Mortality of Rodents Infected with West Nile Virus. PLoS ONE , 7:6, e38672. doi: doi:10.1371/journal.pone.0038672
      • Kumaki, Y., Craig, D., Morrey, J.D, Smee, D., Barnard, D., (2011). In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections. . Antiviral Research/Elsevier, 92:2, 329-340.
      • Julander, J., Hagloch, J., Latimer, S., Motter, N., Dagley, A., Barnard, D., Smee, D., Morrey, J.D, (2011). Use of plethysmography in assessing the efficacy of antivirals in a mouse model of pandemic influenza A virus. Antiviral Research, 92:2, 228-36.
      • Wang, H., Siddharthan, V., Hall, J.O, Morrey, J.D, (2011). Autonomic nervous dysfunction in hamsters infected with West Nile virus. PLoS ONE, 6, e19575.
      • Gowen, B., Julander, J., London, N.R, Wong, M.H, Larson, D., Morrey, J.D, Li, D.Y, Bray, M., (2010). Assessing changes in vascular permeability in a hamster model of viral hemorrhagic fever. Virol. J., 7, 240.
      • Moheno, P., Morrey, J.D, Fuchs, D., (2010). Effect of dipterinyl calcium pentahydrate on hepatitis B virus replication in transgenic mice. Journal of Translational Medicine, 8, 32.
      • Morrey, J.D, Siddharthan, V., Wang, H., Hall, J.O, Motter, N.E, Skinner, R.D, Skirpstunas, R.T, (2010). Neurological suppression of diaphragm electromyographs in hamsters infected with West Nile virus.. Journal of Neurovirology, 16:4, 318-329.
      • Coughlin, J.E, Padmanabhan, S., Zhang, G., Kirt, C.P, Govardhan, B.E, Korba, B.E, O'Loughlin, K., Green, C.E, Mirsalis, J., Morrey, J.D, Iyer, R.P, (2010). Orally bioavailable anti-HBV dinucleotide acyloxyalkyl prodrugs. Bioorg Med Chem Lett, 20, 1783-6.
      • Smee, D., Hurst, B.L, Wong, M., Tarbet, B., Babu, Y.S, Klumpp, K., Morrey, J.D, (2010). Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in mice. Antiviral Res., 88:1, 38-44.
      • Gowen, B., Julander, J., London, N.R, Wong, M.H, Larson, D., Morrey, J.D, Li, D.Y, Bray, M., (2010). Assessing changes in vascular permeability in a hamster model of viral hemorrhagic fever. Virol. J., 7:240, 1-13.
      • Gowen, B., Wong, M.H, Larson, D., Ye, W., Jung, K.H, Sefing, E.J, Skirpstunas, R., Smee, D., Morrey, J.D, Schneller, S.W, (2010). Development of a new Tacaribe arenavirus infection model and its use to explore antiviral activity of a novel aristeromycin analog. PLoS ONE, 5:9, pii: e12760.
      • Lam, A.M, Murakami, E., Espiritu, C., Steuer, H.M, Niu, C., Keilman, M., Bao, H., Zennou, V., Bourne, N., Julander, J., Morrey, J.D, Smee, D., Frick, D.N, Heck, J.A, Wang, P., Nagarathnam, D., Ross, B.S, Sofia, M.J, Otto, M.J, Furman, P.A, (2010). PSI-7851, a pronucleotide of beta-D-2'-fluro-2'-C-methyluridine monophosphate, is a potent and pan-genotype inhibitor of hepatitis C virus replication. Antimicrob. Agents Chemother., 54:8, 3187-3196.
      • Julander, J., Jha, A.K, Choi, J.A, Jung, K.H, Smee, D., Morrey, J.D, Chu, C.K, (2010). Efficacy of 2'-C-methylcytidine against yellow fever virus in cell culture and in a hamster model. Antiviral Res., 86:3, 261-267.
      • Gowen, B., Wong, M., Jung, K., Smee, D., Morrey, J.D, Furuta, Y., (2010). Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease models. Antiviral Res., 86:2, 121-127.
      • Smee, D., Hurst, B.L, Wong, M., Bailey, K.W, Tarbet, B., Morrey, J.D, Furuta, Y., (2010). Effects of combinations of favipiravir (T-705) and oseltamivir on influenza A (H1N1, H3N2, and H5N1) virus infections in mice. Antimicrob. Agents Chemother., 54:1, 126-133.
      • Roth, J.P, Li, J.K, Smee, D.F, Morrey, J.D, Barnard, D.L, (2009). A recombinant, infectious human parainfluenza virus type 3 expressing the enhanced green fluorescent protein for use in high-throughput antiviral assays. Antiviral Research, 82, 12-21.
      • Morrey, J.D, (2009). Alkoxyalkyl esters of (S)-HPMPA are potent and selective inhibitors of hepatitis B virus replication in vitro and in transgenic hepatitis B mice in vivo. Antimicrobial Agents and Chemotherapy, 53, 2865-70.
      • Mendenhall, M., Wong, M.H, Skirpstunas, R., Morrey, J.D, Gowen, B., (2009). Punta Toro virus (Bunyaviridae, Phlebovirus) infection in mice: strain differences in pathogenesis and host interferon response.. Virology, 395, 143-51.
      • Day, C.W, Baric, R., Cai, S.X, Freeman, M., Kumaki, Y., Morrey, J.D, Smee, D., Barnard, D., (2009). A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo . Virology, 395:2, 210-222.
      • Morrey, J.D, (2009). A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo. Virology, (accepted)
      • Morrey, J.D, (2009). Effect of T-705 on western equine encephalitis in a mouse model. Antiviral Research, 82, 169-71.
      • Morrey, J.D, (2009). Effects of combinations of favipiravir (T-705) and oseltamivir on influenza A (H1N1, H3N2, and H5N1) virus infections in mice. Antimicrobial Agents and Chemotherapy, (accepted)
      • Morrey, J.D, (2009). Effects of double combinations of amantadine, oseltamivir, and ribavirin on influenza A (H5N1) virus infections in cell culture and in mice. Antimicrobial Agents and Chemotherapy, 53, 2120-8.
      • Morrey, J.D, (2009). Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease models. Antiviral Research, (accepted)
      • Morrey, J.D, (2009). Persistent West Nile virus associated with a neurological sequela in hamsters identified by motor unit number estimation. Journal of Virology, 83, 4251-61.
      • Morrey, J.D, (2009). Punta toro virus (Bunyaviridae, Phlebovirus) infection in mice: Strain differences in pathogenesis and host interferon response. Virology, (in press Epub)
      • Morrey, J.D, (2009). T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections. Antiviral Research, 82, 95-102.
      • Julander, J., Smee, D., Morrey, J.D, Furuta, Y., (2009). Effect of T-705 treatment on western equine encephalitis in a mouse model. Antiviral Res., 82:3, 169-171.
      • Furuta, Y., Takahashi, K., Shiraki, K., Sakamoto, K., Smee, D., Barnard, D., Gowen, B., Julander, J., Morrey, J.D, (2009). T-705 (favipiravir) and related compounds: novel broad-spectrum inhibitors of RNA viral infections. Antiviral Res, 82:3, 95-102.
      • Smee, D., Hurst, B.L, Wong, M., Bailey, K.W, Morrey, J.D, (2009). Effects of double combinations of amantadine, oseltamivir, and ribavirin on influenza A (H5N1) virus infections in cell culture and in mice. Antimicrob. Agents Chemother., 53, 2120-2128.
      • Roth, J.P, Li, J.K, Smee, D., Morrey, J.D, Barnard, D., (2009). A recombinant, infectious human parainfluenza virus type 3 expressing the enhanced green fluorescent protein for use in high-throughput antiviral assays. Antiviral Res., 82:1, 12-21.
      • Julander, J., Shafer, K., Smee, D., Morrey, J.D, Furuta, Y., (2009). Activity of T-705 in a hamster model of yellow fever virus infection in comparison with a chemically related compound T-1106. Antimicrob. Agents Chemother., 53:1, 202-209.
      • Julander, J., Shafer, K., Smee, D., Morrey, J.D, Furuta, Y., (2009). Activity of T-705 in a hamster model of yellow fever virus infection in comparison with a chemically related compound T-1106. Antimicrob. Agents Chemother., 53:1, 202-209.
      • Gowen, B., Fairman, J., Dow, S.W, Troyer , R., Wong, M.H, Jung, K.H, Melby, P.C, Morrey, J.D, (2009). Prophylaxis with cationic liposome-DNA complexes protects hamsters from phleboviral disease: Importance of liposomal delivery and CpG motifs.. Antiviral Res, 81:1, 37-46.
      • Morrey, J.D, (2008). West Nile virus-induced acute flaccid paralysis is prevented by monoclonal antibody treatment even after infection of spinal cord neurons. Journal of Neurovirology, 14, 152-63.
      • Morrey, J.D, Taro, B.S, Siddharthan, V., Wang, H., Smee, D., Christensen, A.J, Furuta, Y., (2008). Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodents. Antiviral Res., 80:3, 377-379.
      • Julander, J., Bowen, R.A, Rao, J.R, Day, C., Shafer, K., Smee, D., Morrey, J.D, Chu, C.K, (2008). Treatment of Venezuelan equine encephalitis virus infection with (-)-carbodine. Antiviral Res., 80:3, 309-315.
      • Julander, J., Bowen, R.A, Rao, J.R, Day, C., Shafer, K., Smee, D., Morrey, J.D, Chu, C.K, (2008). Treatment of Venezuelan equine encephalitis virus infection with (-)-carbodine. Antiviral Res., 80:3, 309-315.
      • Gowen, B., Smee, D., Wong, M., Hall, J.O, Jung, K., Bailey, K.W, Stevens, J.R, Furuta, Y., Morrey, J.D, (2008). Treatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirin. PLoS ONE, 3:11, e3725.
      • Gowen, B., Judge, J.W, Wong, M.H, Jung, K.H, Aylsworth, C.F, Melby, P.C, Rosenberg, B., Morrey, J.D, (2008). Immunoprophylaxis of Punta Toro virus (Phlebovirus, Bunyaviridae) infection in hamsters with recombinant Eimeria profilin-like antigen.. Int. Immunopharmacol., 8, 1089-94.
      • Julander, J., Skirpstunas, R., Siddharthan, V., Shafer, K., Hoopes, J.D, Smee, D., Morrey, J.D, (2008). C3H/HeN mouse model for the evaluation of antiviral agents for the treatment of Venezuelan equine encephalitis virus infection. Antiviral Res., 78:3, 230-241.
      • Julander, J., Skirpstunas, R., Siddharthan, V., Shafer, K., Hoopes, J.D, Smee, D., Morrey, J.D, (2008). C3H/HeN mouse model for the evaluation of antiviral agents for the treatment of Venezuelan equine encephalitis virus infection. Antiviral Res., 78:3, 230-241.
      • Morrey, J.D, (2008). Activity of T-705 in a hamster model of yellow fever virus infection in comparison with a chemically related compound T-1106. Antimicrobial Agents and Chemotherotherapy, 53, 202-9.
      • Morrey, J.D, (2008). C3H/HeN mouse model for the evaluation of antiviral agents for the treatment of Venezuelan equine encephalitis virus infection. Antiviral Research, 78, 230-41.
      • Morrey, J.D, (2008). Efficacy of cationic lipd-DNA complexes (CLDC) on hepatitis B virus in transgenic mice. Antiviral Research, 79, 71-9.
      • Morrey, J.D, (2008). Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodents. Antiviral Research, 80, 377-9.
      • Morrey, J.D, (2008). Immunoprophylaxis of Punta Toro virus (Phlebovirus, Bunyaviridae) infection in hamsters with recombinant Eimeria profilin-like antigen.. International Immunopharmacology, 8, 1089-94.
      • Morrey, J.D, (2008). Increased blood-brain-barrier permeability not a primary determinant for lethality of West Nile virus infection of rodents. Journal of General Virology, 89, 467-73.
      • Morrey, J.D, (2008). Prophylaxis with cationic liposome-DNA complexes protects hamsters from phleboviral disease: Importance of liposomal delivery and CpG motifs. Antiviral Research, 81, 37-46.
      • Morrey, J.D, (2008). Treatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirin. PLoS One, 3, 3725.
      • Morrey, J.D, (2008). Treatment of Venezuelan equine encephalitis virus infection with (-)-carbodine. Antiviral Research, 80, 309-15.
      • Morrey, J.D, (2007). Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice. Antimicrobial Agents and Chemotherapy, 51, 845-51.
      • Morrey, J.D, (2007). Axonal transport mediates West Nile virus entry into the central nervous system and induces acute flaccid paralysis.. Proc. Natl. Acad. Sci USA, 104, 17140-5.
      • Morrey, J.D, Siddharthan, V., Olsen, A.L, Wang, H., Julander, J., Hall, J.O, Li, H., Nordstrom, J.L, Koenig, S., Johnson, S., Diamond, M.S, (2007). Defining limits of treatment with humanized neutralizing monoclonal antibody for West Nile virus neurological infection in a hamster model.. Antimicrob. Agents Chemother., 51 (7), 2396-402.
      • Morrey, J.D, (2007). Caspase-3 dependent cell death of neurons contributes to the pathogenesis of West Nile virus encepthalitis. Journal of Virology, 81, 2614-23.
      • Morrey, J.D, (2007). Correlation between breakdown of the blood-brain-barrier and disease outcome of viral encepthalitis in mice. Antiviral Res., 75:104-112
      • Morrey, J.D, (2007). Defining the limit of effective treatment for West Nile virus neurological infection with a humanized neutralizing monoclonal antibody.. Antimicrob. Agents Chemother., 51, 2396-2402.
      • Morrey, J.D, Siddharthan, V., Olsen, A.L, Roper, G.Y, Wang, H., Baldwin, T.J, Koenig, S., Johnson, S., Nordstrom, J.L, Diamond, M.S, (2007). Humanized monoclonal antibody against West Nile virus E protein administered after neuronal infection protects against lethal encephalitis in hamsters.. The Journal of Infectious Diseases, 194, 1300-8.
      • Morrey, J.D, (2007). Neutralizing viruses in suspensions by copper oxide based filters.. Antimicrob Agents Chemother, 51, 2605-2607.
      • Julander, J., Siddharthan, V., Blatt, L.M, Shafer, K., Sidwell, R.W, Morrey, J.D, (2007). Effect of exogenous interferon and an interferon inducer on western equine encephalitis virus disease in a hamster model. Virology, 360:2, 454-460.
      • Julander, J., Morrey, J.D, Blatt, L.M, Shafer, K., Sidwell, R.W, (2007). Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model. Antiviral Res., 73:2, 140-146.
      • Stuyver, L.J, McBrayer, T.R, Tharnish, P.M, Clark, J., Hollecker, L., Lostia, S., Nachman, T., Grier, J., Bennett, M.A, Xie, M.Y, Schinazi, R.F, Morrey, J.D, Julander, J., Furman, P.A, Otto, M.J, (2006). Inhibition of hepatitis C replicon RNA synthesis by beta-D-2'-deoxy-2'fluoro-2'-C-methylcytidine: a specific inhibitor of hepatitis C virus replication. Antiv. Chem. Chemother., 17:2, 79-87.
      • Morrey, J.D, (2006). A porphyrin increases survival time of mice after intracerebral prion infection.. Antimicrobial Agents and Chemotherotherapy, 50, 759-61.
      • Morrey, J.D, (2006). Effect of exogenous interferon and an interferon inducer on western equine encephalitis virus disease in a hamster model.. Virology, 360, 454-460.
      • Morrey, J.D, (2006). Enhanced antiscrapie effect using combination drug treatment.. Antimicrob Agents Chemother., 50, 3447-3449.
      • Morrey, J.D, (2006). Humanized monoclonal antibody against West Nile virus E protein administered after neuronal infection protects against lethal encephalitis in hamsters. Journal of Infectious Disease, 194, 1300-08.
      • Morrey, J.D, (2006). Inhibition of hepatitis C replicon RNA synthesis by b-d-2'-deoxy-2'-fluoro-2'-C-methylcytidine: a specific inhibitor of hepatitis C virus replication.. Antiviral Chemistry and Chemotherapy, 17, 79-87.
      • Morrey, J.D, (2006). Inhibition of West Nile virus replication by synthetic oligonucleotides. Antiviral Res, 70(2), 60-5.
      • Morrey, J.D, (2006). West Nile virus infection of the placenta.. Virology, 347, 175-82.
      • Julander, J., Winger, Q.A, Rickords, L.F, Shi, P.Y, Tilgner, M., Binduga-Gajewska, I., Sidwell, R.W, Morrey, J.D, (2006). West Nile virus infection of the placenta.. Virology, 347:1, 175-182.
      • Day, C.W, Smee, D., Julander, J., Yamshchikov, V.F, Sidwell, R.W, Morrey, J.D, (2005). Error-prone replication of West Nile virus caused by ribavirin.. Antiviral Res., 67:1, 38-45.
      • Morrey, J.D, (2005). Broad-spectrum inhibitor of viruses in the Flaviviridae family. Antiviral Research, 68, 49-55.
      • Morrey, J.D, (2005). Error-prone replication of West Nile virus caused by ribavirin. Antiviral Research, 67, 38-45.
      • Morrey, J.D, (2005). Nucleotide analogs as novel anti-hepatitis B virus agents.. Current Opinions in Pharmacology, 5, 520-528.
      • Morrey, J.D, (2005). Treatment of West Nile virus-infected mice with reactive immumoglobulin reduces fetal titers and increases dam survival. Antiviral Research, 65, 79-85.
      • Julander, J., Winger, Q.A, Olsen, A.L, Day, C.W, Sidwell, R.W, Morrey, J.D, (2005). Treatment of West Nile virus-infected mice with reactive immunoglobulin reduces fetal titers and increased dam survival. Antiviral Res., 65:2, 79-85.
      • Morrey, J.D, Day, C.W, Julander, J., Olsen, A.L, Sidwell, R.W, Cheney, C.D, Blatt, L.M, (2004). Modeling hamsters for evaluating West Nile virus therapies.. Antiviral Res., 63:1, 41-50.
      • Morrey, J.D, (2004). Anti-hepatitis B virus activity of ORI-9020, a novel phosphorothioate dinucleotide, in a transgenic mouse model. Antimicrobial Agents and Chemotherapy, 48(6), 2318-2320.
      • Morrey, J.D, (2004). Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models. Antiviral Chemistry and Chemotherapy, 15, 101-109.
      • Morrey, J.D, (2004). Evaluation of new cell culture inhibitors of protease-resistant prion protein against scrapie infection in mice. Journal of General Virology, 85(Pt 8), 2479-83.
      • Morrey, J.D, (2004). Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and b-D-N4-hydroxycytidine. Antiviral Chemistry and Chemotherapy, 15, 15-22.
      • Morrey, J.D, (2004). Modeling hamsters for evaluating West Nile virus therapies. Antiviral Research, 63(1), 41-50.
      • Morrey, J.D, (2004). Phosphorothioate di- and tri-nucleotides as a novel class of anti-HBV agents. Antimicrobial Agents and Chemotherapy, 48(6), 2199-2205.
      • Morrey, J.D, (2004). Transgenic HBV mouse model in the study of HBV. Methods in Molecular Medicine: Hepatitis B and D Protocols, 96, 239-52.
      • Iyer, R.P, Roland, A., Jin, Y., Mounir, S., Korba, B., Julander, J., Morrey, J.D, (2004). Anti-hepatitis B virus activity of ORI-9020, a novel phosphorothioate dinucleotide, in a transgenic mouse model.. Antimicrob Agents Chemother, 48:6, 2318-2320.
      • Morrey, J.D, Day, C.W, Julander, J., Blatt, L.M, Smee, D., Sidwell, R.W, (2004). Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models.. Antivir Chem Chemother, 15:2, 101-109.
      • Julander, J., Colonno, R.J, Sidwell, R.W, Morrey, J.D, (2003). Characterization of antiviral activity of entecavir in transgenic mice expressing hepatitis B virus.. Antiviral Res, 59:3, 155-161.
      • Morrey, J.D, (2003). A self-processing ribozyme cassette: utility against human papillomavirus 11 E6/E7 mRNA and hepatitis B virus. Molecular Therapy, 9, 596-606.
      • Morrey, J.D, (2003). Inhibition of influenza virus infections in immunosuppressed mice with orally administered Peramivir (BCX-1812). Antiviral Research, 60, 17-25.
      • Sidwell, R.W, Bailey, K.W, Morrey, J.D, Wong, M.H, Baldwin, T.J, Smee, D., (2003). Inhibition of influenza virus infections in immunosuppressed mice with orally administered Peramivir (BCX-1812).. Antiviral Research, 60, 17-25.
      • Julander, J., Sidwell, R.W, Morrey, J.D, (2002). Characterizing antiviral activity of adefovir dipivoxil in transgenic mice expressing hepatitis B virus. Antiviral Res., 55:1, 27-40.
      • Morrey, J.D, (2002). Characterization of antiviral activity of entecavir in transgenic mice expressing hepatitis B virus. Antiviral Research, 59, 155-161.
      • Morrey, J.D, (2002). Characterization of nuclease-resistant ribozymes directed against hepatitis B virus RNA. J. Viral. Hepat., 9(6), 411-8.
      • Morrey, J.D, (2002). Characterizing antiviral activity of adefovir dipivoxil in transgenic mice expressing hepatitis B Virus. Antiviral Research, 55, 27-40.
      • Morrey, J.D, (2002). Identification of active compounds against a New York isolate of West Nile virus. Antiviral Research, 55, 107-116.
      • Morrey, J.D, (2001). Appetite is not influenced by a unique milk peptide: caseinomacropeptide (CMP). Appetite, 36(2), 157-63.
      • Morrey, J.D, (2001). Enantiomeric synthesis of D- and L-cyclopentenyl nucleosides and their antiviral activity against HIV and West Nile virus. J. Med. Chem., 44(23), 3985-3993.
      • Morrey, J.D, (2001). In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201. Antimicrobial Agents and Chemotherapy, 45(3), 749-57.
      • Morrey, J.D, (2001). Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWH-270201. Antiviral Research, 51, 179-187.
      • Morrey, J.D, (2001). Transgenic mice carrying a gene for green fluorescent protein fused to a lytic peptide, shiva 1, under control of the bovine B-casein regulatory region. Transgenics, 3, 183-197.
      • Morrey, J.D, (1999). Development of nuclear transfer and parthenogenetic rabbit embryos activated with inositol 1,4,5-trisphophate. Biology of Reproduction, 60, 821-827.
      • Morrey, J.D, (1999). Resistance to Friend leukemia virus in transgenic mice expressing the native FV-4 gene. Acta Virologica, 43, 19-23.
      • Morrey, J.D, (1999). Utilization of transgenic mice replicating high levels of hepatitis B virus for antiviral evaluation of lamivudine. Antiviral Research, 42, 97-108.
      • Morrey, J.D, (1997). Interleukin 2 promoter/enhancer controlled expression of a synthetic cecropin-class lytic peptide in transgenic mice and subsequent resistance to Brucella abortus.. Transgenic Research, 6, 337-347.
      • Morrey, J.D, (1996). Progression of Aleutian mink disease in natural and experimental infections. Amer. J. of Vet. Res., 57, 1753-1758.
      • Morrey, J.D, (1996). Progression of Aleutian mink disease in natural and experimental infections. Amer. J. of Vet. Res., 57, 1753-1758.
      • Morrey, J.D, (1995). Activation of the human immunodeficiency virus long terminal repeat by abrasion of the skin in transgenic mice. Intervirology, 37, 315-320.
      • Morrey, J.D, (1995). Special Topics Issue, Cell Biology of Embryogenesis. Theriogenology 48:1059-1212, 48, 1059-1212.
      • Bunch, T.D, White, K.L, Morrey, J.D, Barnes, F.L, (1995). Special Topics Issue, Cell Biology of Embryogenesis. Theriogenology, 48, 1059-1212.
      • Morrey, J.D, (1994). Importance of primer selection in application of PCR technology to diagnosis of bovine leukemia virus. Journal of Veterinary Diagnostic Investigation, 6, 297-301.
      • Morrey, J.D, (1993). Activation of the human immunodeficiency virus type 1 long terminal repeat by skin-sensitizing chemicals in transgenic mice. Intervirology, 36, 65-71.
      • Morrey, J.D, Jackson, M.K, Bunch, T.D, Sidwell, R.W, (1993). Activation of the human immunodeficiency virus type 1 long terminal repeat by skin-sensitizing chemicals in transgenic mice. Intervirol., 36, 65-71.
      • Morrey, J.D, (1993). Aleutian Disease: Current Status and Developments. Blue Book of Farming, 1, 5-Apr.
      • Morrey, J.D, (1993). Early detection of bovine leukemia virus in experimentally infected cattle by use of the polymerase chain reaction. Amer. J. of Vet. Res., 54, 205-209.
      • Morrey, J.D, (1993). Early detection of bovine leukemia virus in experimentally infected cattle by use of the polymerase chain reaction. Amer. J. of Vet. Res., 54, 205-209.
      • Morrey, J.D, (1993). Effect of immunomodulators in the hu-PBL-SCID mouse model. Biotechnology Therapeutics, 4, 133-143.
      • Morrey, J.D, (1993). Immunomodulator effects on the Friend virus infection in genetically defined mice. Ann. N.Y. Acad. Sci., 685, 432-446.
      • Morrey, J.D, (1992). Elucidation of mode of retroviral-inhibitory effects of imexon through use of immune competent and severe combined immune deficiency (SCID) mice. Antiviral Research, 17, 223-233.
      • Morrey, J.D, (1992). Experiences with biological response modifiers in animal models for AIDS.. Recent Adv. Chemother., 1, 934-935.
      • Morrey, J.D, (1992). Ganciclovir treatment of murine cytomegalovirus infection in mice immunosuppressed by prior infection with friend leukemia virus. Antiviral Chemistry and Chemotherapy, 3, 327-333.
      • Morrey, J.D, (1992). HIV-1 LTR activation model: Evaluation of various agents in skin of transgenic mice. Journal of Acquired Immune Deficiency Syndromes, 5, 1195-1203.
      • Morrey, J.D, Bourn, S.M, Bunch, T.D, Sidwell, R.W, Rosen, C.A, (1992). HIV-1 LTR activation model: Evaluation of various agents in skin of transgenic mice. J. of AIDS., 5, 1195-1203.
      • Morrey, J.D, (1992). Murine retroviral disease enhancing effects of a pyrimidinone immunomodulator. Antiviral Research, 19, 233-245.
      • Morrey, J.D, (1992). Suppression of murine retroviral disease by 2', 3'-dideoxythymidine (D4T).. Antiviral Research, 19, 313-324.
      • Morrey, J.D, (1991). Early-initiated Zidovudine therapy prevents disease but not low levels of persistent retrovirus in mice. Journal of Acquired Immune Deficiency Syndromes, 4, 506-512.
      • Morrey, J.D, (1991). In vivo activation of human immunodeficiency virus type 1 long terminal repeat by UV type A (UV-A) light plus psoralen and UV-B light in the skin of transgenic mice. Journal of Virology, 65, 5045-5051.
      • Morrey, J.D, Bourn, S.M, Bunch, T.D, Sidwell, R.W, Barrows, L.R, Daynes, R.A, Rosen, C.A, (1991). In vivo activation of human immunodeficiency virus type 1 long terminal repeat by UV type A (UV-A) light plus psoralen and UV-B light in the skin of transgenic mice. J. Virol., 65, 5045-5051.
      • Morrey, J.D, (1991). In vivo regulation of HIV-1 long terminal repeat by UV light and various skin applicants in transgenic mice. Journal of Acquired Immune Deficiency Syndromes, 4, 328-329.
      • Morrey, J.D, Bourn, S.M, Bunch, T.D, Sidwell, R.W, Barrows, L.R, Daynes, R.A, Rosen, C.A, (1991). In vivo regulation of HIV-1 long terminal repeat by UV light and various skin applicants in transgenic mice. J. AIDS., 4, 328.
      • Morrey, J.D, (1991). Two-cell blockage of FVB/N embryo development: An artifact of cell culture. Encylcia, 78, 275-284.
      • Morrey, J.D, Bourn, S., Sidwell, R.W, Sisson, D.V, Bunch, T.D, Flood, M.R, (1991). Two-cell blockage of FVB/N mouse embryo development: An artifact of cell culture. Encylia., 68, 275-284.
      • Morrey, J.D, (1990). A mouse genetics model for evaluation of biological response modifiers for the treatment of retroviral infection. J. Cell. Biochem., 140, 68-70.
      • Morrey, J.D, (1990). Effect of Imexon on friend virus complex infection in Rfv-3r/s genotype-containing mice as a model for AIDS. Ann. N.Y. Acad. Sci. 616:575-578, 616, 575-578.
      • Morrey, J.D, (1990). Effect of imexon treatment on Friend virus infection using genetically defined mice as a model for HIV infection. Antiviral Research, 15, 51-66.
      • Morrey, J.D, (1990). Effects of zidovudine on Friend virus complex infection in Rfv-3r/s genotype-containing mice used as a model for HIV infection. Journal of Acquired Immune Deficiency Syndromes, 3, 500-510.
      • Morrey, J.D, (1987). Staphylococcus of turkeys: 1. Portal of entry and tissue colonization.. Journal of Avian Diseases, 31, 64-69.
      • Morrey, J.D, (1987). Tissue-specific replication of Friend and Moloney murine leukemia viruses in infected mice.. Journal of Virology, 61, 1350-1357.
      • Morrey, J.D, (1984). Effects of folic acid malnutrition on rotaviral infection in mice. Proceedings of the Society of Experimental Biology and Medicine, 1766, 77-83.
      • Professional Journal

      • Julander, J., Bantia, S., Taubenheim, B.R, Minning, D.M, Kotian, P., Morrey, J.D, Smee, D., Sheridan, W.P, Babu, Y.S, (2014). BCX4430, a novel nucleoside analog, effectively treats yellow fever in a hamster model. Antimicrobial Agents and Chemotherapy, 58:11, 6607-6614.
      • Wang, H., Siddharthan, V., Kesler, K., Hall, J.O, Motter, N.E, Julander, J., Morrey, J.D, (2013). Autonomic Deficit not the Cause of Death in West Nile Virus Neurological Disease. J Infect Dis, 204:4, 573-583.
      • Wand, H., Siddharthan, V., Kesler, K., Hall, J.O, Motter, N.E, Julander, J., Morrey, J.D, (2013). Autonomic Deficit not the Cause of Death in West Nile Virus Neurological Disease. J Infect Dis, 204:4, 573-583.
      • Julander, J., Ennis, J., Turner, J., Morrey, J.D, (2011). Treatment of yellow fever virus with an adenovirus-vectored interferon, DEF201, in a hamster model. Antimicrob. Agents Chemother., 55:5, 2067-73.
      • Wang, H., Siddharthan, V., Hall, J.O, Morrey, J.D, (2009). West Nile virus preferentially transports along motor neuron axons after sciatic nerve injection of hamsters. Journal of Neurovirology, 15, 293-4.
      • Morrey, J.D, (1992). Early detection of Aleutian disease virus in mink by polymerase chain reaction. Nor. J. Agr. Sci., 9, 383-387. *

      * Has not been peer reviewed

      Publications - Literary Journal

        * Has not been peer reviewed

        Publications - MultiMedia

          * Has not been peer reviewed

          Publications - Technical Reports

            Research Reports

          • Morrey, J.D, Barnard, D., Smee, D., Gowen, B., (2009). Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
          • Smee, D., Barnard, D., Morrey, J.D, Gowen, B., Julander, J., (2009). Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
          • Morrey, J.D, Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2009). Semi-Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
          • Morrey, J.D, Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2009). Semi-Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
          • Smee, D., Barnard, D., Morrey, J.D, Gowen, B., Julander, J., (2009). Semi-Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
          • Morrey, J.D, Barnard, D., Smee, D., Gowen, B., (2008). Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
          • Morrey, J.D, Barnard, D., Smee, D., Gowen, B., (2008). Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
          • Smee, D., Barnard, D., Morrey, J.D, Gowen, B., Julander, J., (2008). Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
          • Morrey, J.D, Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2008). Semi-Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
          • Morrey, J.D, Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2008). Semi-Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
          • Smee, D., Barnard, D., Morrey, J.D, Gowen, B., Julander, J., (2008). Semi-Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
          • Morrey, J.D, Barnard, D., Smee, D., Gowen, B., (2007). Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
          • Smee, D., Barnard, D., Morrey, J.D, Gowen, B., Julander, J., (2007). Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
          • Morrey, J.D, Barnard, D., Smee, D., Gowen, B., (2007). Semi-Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
          • Smee, D., Barnard, D., Morrey, J.D, Gowen, B., Julander, J., (2007). Semi-Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
          • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2006). Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
          • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., Julander, J., (2006). Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
          • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., Julander, J., (2006). Semi Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
          • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2006). Semi-Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
          • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2005). Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
          • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2005). Semi Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
          • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2005). Semi-Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
          • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2004). Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
          • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2004). Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
          • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2004). Semi Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
          • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2004). Semi-Annual Report NO1-AI-15435, NIAID, NIH. Animals Models of Human Experimental Viral Infections for Evaluation of Experimental Therapies.
          • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2003). Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
          • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2003). Semi Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
          • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2002). Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
          • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2002). Semi Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
          • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2001). Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
          • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2001). Semi Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
          • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2000). Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
          • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (2000). Semi Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
          • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (1999). Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .
          • Sidwell, R., Barnard, D., Morrey, J.D, Smee, D., Gowen, B., (1999). Semi Annual Report NO1-AI-85348, NIAID, NIH. In vitro antiviral screen for respiratory viruses. .

          * Has not been peer reviewed

          Publications - Translations & Transcripts

            Publications - Other

              Other

            • Morrey, J.D, (1999). Transgenic mice as a chemotherapeutic model for hepatitis B virus infection. Antiviral Ther. *
            • Morrey, J.D, (1998). Protein Production in the Milk of Genetically Engineered Animals. M.S., Animal Science, Dept. of Animal, Dairy & Veterinary Sciences, Utah State University, Logan, UT *
            • Morrey, J.D, (1998). Protein Production in the Milk of Genetically Engineered Animals. M.S., Animal Science, Dept. of Animal, Dairy & Veterinary Sciences, Utah State University, Logan, UT *
            • Morrey, J.D, (1995). Effect of the combination of interferon-alpha and stavudine on Friend virus infections in (B10.A X A.By)F1 mice. Journal of Infectious Diseases *
            • Morrey, J.D, (1994). Cytokines as potential therapies for human immunodeficiency virus infections. Canadian Journal of Infectious Diseases *
            • Morrey, J.D, (1992). Early detection of Aleutian disease virus in mink by polymerase chain reaction. Nor. J. Agr. Sci. *
            • Morrey, J.D, (1992). Transgenic mice as models for photo-induced gene expression: Activation of human immunodeficiency virus long terminal repeat. Journal of Photochemistry and Photobiology *
            • Morrey, J.D, Bourn, S.M, Jackson, M.K, Bunch, T.D, Sidwell, R.W, Barrows, L.R, Daynes, R.A, (1992). Transgenic mice as models for photo-induced gene expression: Activation of human immunodeficiency virus long terminal repeat. J. of Photochemistry and Photobiology *
            • Morrey, J.D, (1991). New models of murine cytomegalovirus infection in immunocompromised mice. Antiviral Res. 15(Suppl. 1):133 *

            * Has not been peer reviewed